Journal
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume 41, Issue 1, Pages 92-128Publisher
SPRINGER
DOI: 10.1007/s11239-015-1309-0
Keywords
Pregnancy; Obstetric; Venous thromboembolism; Pulmonary embolism; Deep vein thrombosis; Prophylaxis; Anticoagulants
Funding
- Boehringer Ingelheim
- Daiichi Sankyo
- Janssen Pharmaceuticals
Ask authors/readers for more resources
Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep vein thrombosis (DVT), is a serious and potentially fatal condition. Treatment and prevention of obstetric-related VTE is complicated by the need to consider fetal, as well as maternal, wellbeing when making management decisions. Although absolute VTE rates in this population are low, obstetric-associated VTE is an important cause of maternal morbidity and mortality. This manuscript, initiated by the Anticoagulation Forum, provides practical clinical guidance on the prevention and treatment of obstetric-associated VTE based on existing guidelines and consensus expert opinion based on available literature where guidelines are lacking.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available